85 participants
Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-12
- Start Date:
- 2017-10-26
- Completion:
- 2021-11-30
Conditions
- Renal Cancer
Interventions
- DRUG